Bispecific antibody platforms for cancer immunotherapy

R. Lameris; R.C.G. de Bruin; F.L. Schneiders; P.M. Henegouwen; H.M.W. Verheul; T.D. de Gruijl; H.J. van der Vliet

doi:10.1016/j.critrevonc.2014.08.003

Bispecific antibody platforms for cancer immunotherapy

R. Lameris
, R.C.G. de Bruin
, F.L. Schneiders
, P.M. Henegouwen
, H.M.W. Verheul
, T.D. de Gruijl
, H.J. van der Vliet

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	153-165
Journal	Critical reviews in oncology/hematology
Volume	92
Issue number	3
DOIs	https://doi.org/10.1016/j.critrevonc.2014.08.003
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.critrevonc.2014.08.003

Cite this

@article{6c92af1d144c4f6aa429bb2b67a396b0,

title = "Bispecific antibody platforms for cancer immunotherapy",

author = "R. Lameris and \{de Bruin\}, R.C.G. and F.L. Schneiders and P.M. Henegouwen and H.M.W. Verheul and \{de Gruijl\}, T.D. and \{van der Vliet\}, H.J.",

year = "2014",

doi = "10.1016/j.critrevonc.2014.08.003",

language = "Undefined/Unknown",

volume = "92",

pages = "153--165",

journal = "Critical reviews in oncology/hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

number = "3",

}

TY - JOUR

T1 - Bispecific antibody platforms for cancer immunotherapy

AU - Lameris, R.

AU - de Bruin, R.C.G.

AU - Schneiders, F.L.

AU - Henegouwen, P.M.

AU - Verheul, H.M.W.

AU - de Gruijl, T.D.

AU - van der Vliet, H.J.

PY - 2014

Y1 - 2014

U2 - 10.1016/j.critrevonc.2014.08.003

DO - 10.1016/j.critrevonc.2014.08.003

M3 - Article

C2 - 25195094

SN - 1040-8428

VL - 92

SP - 153

EP - 165

JO - Critical reviews in oncology/hematology

JF - Critical reviews in oncology/hematology

IS - 3

ER -